BURNABY, British Columbia and MISSISSAUGA, Ontario, September 26, 2023 – LifeLabs, the most trusted brand in health diagnostic services* and Abbott, the global healthcare company, have launched an innovative collaboration to support British Columbians living with diabetes and their healthcare teams.
This collaboration, known as the FreeStyle Easy Access program, enables British Columbians to send their FreeStyle Libre® glucose data directly to their healthcare provider’s electronic medical records (EMR) system. As a result, care teams will receive quicker, more convenient access to vital information to inform more individualized treatment plans.
“A key component to supporting Canadians in making informed decisions about their health is offering digital services such as our online health portal, MyCareCompass, that moves the narrative beyond chronic conditions to focus more on the overall quality of life,” said Lawrence Mahan, senior vice president of commercial, business and consumer markets at LifeLabs.
“We’re excited to partner with Abbott to continue offering healthcare providers and their patients living with chronic conditions, like diabetes, greater access to valuable information that will support them in managing their health.”
“Around the world, Abbott’s FreeStyle Libre systems provides over 5 million individuals living with diabetes and their healthcare teams with accurate, actionable insights through connected platforms and apps,” said Luz Herrera, general manager of Abbott’s diabetes care business in Canada. “This collaboration with LifeLabs is an excellent example of how together, we are driving the future of integrated diabetes care to deliver connected, personalized care and ultimately, improve the lives of those living with this chronic condition.”
“In my practice, we care for more than 360 patients living with diabetes. Together, we value effective technology solutions to support individualized care and ongoing information to guide diabetes management and medication decisions,” said Dr. Daniel Ngui, clinical professor of family medicine and director of Fraser Street Medical in Vancouver. “Automatically importing key glucose data and metrics into electronic medical records enables me, as well as other clinicians, to analyze what is really happening for my patients both in and outside of my office walls. This will support more meaningful conversations with my patients and optimize personalized treatment plans.”
LifeLabs and Abbott’s collaboration represents a milestone in the healthcare industry, combining the power of technology and collaboration to meet the specific needs of British Columbians living with diabetes.
LifeLabs is Canada’s leading provider of laboratory diagnostic information and digital health connectivity systems, enabling patients and healthcare practitioners to diagnose, treat, monitor, and prevent disease. We support 20 million patient visits annually and conduct over 100 million laboratory tests through leading edge technologies and our 7,000+ talented and dedicated employees. We are a committed innovator in supporting Canadians to live healthier lives, operating Canada’s first commercial genetics lab, and the country’s largest online patient portal, with more than 5 million Canadians receiving their results online. LifeLabs has been named one of Canada’s Best Employers (2021, 2022, 2023) and Best Employers for Diversity (2022, 2023) by Forbes, and recognized for having an award-winning Mental Health Program from Benefits Canada. LifeLabs is 100% Canadian owned by OMERS Infrastructure, the infrastructure investment manager of one of Canada’s largest defined benefit pension plans. Learn more at www.lifelabs.com.
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 115,000 colleagues serve people in more than 160 countries.
Connect with us at www.abbott.com.
Stacey Brown, Abbott Public Affairs
*LifeLabs awarded most trusted brand in health diagnostic services by market research firm BrandSpark, 2023.